LGND
Ligand Pharmaceuticals Incorporated
$203.27
+$3.67(+1.84%)
61
Overall
55
Value
60
Tech
68
Quality
Market Cap
$3.56B
Volume
195.64K
52W Range
$93.58 - $227.92
Target Price
$245.10
EPS Estimates Overview
| Current Quarter | $1.01 | Next Quarter | $1.2 |
| Current Year | $5.47 | Next Year | $6.63 |
| QoQ Growth | +18.8% | YoY Growth | +21.2% |
| 3Y EPS CAGR | -40.3% | Target Price | $245.10 |
| Consensus | Buy | Upside | +20.6% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | LGND | $203.27 | +1.8% | 195.64K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Ligand Pharmaceuticals Incorporated Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW